India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say

By Khushi Malhotra and Dharamraj DhutiaIndia's Sun Pharmaceutical Industries NSE:SUNPHARMA is planning to raise around 100 billion rupees ($1.04 billion) via a rupee-denominated debt sale to partly fund a bridge loan it took to acquire US healthcare firm Organon & Co., three sources said on Tuesday…